NCT05865717 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Achievements in Public Health, 1900-1999: Changes in the Public Health System
(1999). Centers for Disease Control and Prevention.
Gonzalez K, Fuentes J, Marquez JL
Physical Inactivity, Sedentary Behavior and Chronic Diseases. Korean J Fam Med. 2017 May;38(3):111-115. doi: 10.4082/kjfm.2017.38.3.111. Epub 2017 May 23.
Khan, S
E. (2020). Exploring socio-cultural factors influencing adherence to the treatment of type 2 diabetes in rural Sargodha. Quaid-i-Azam University, Islamabad
Khan, S
E. (2021). Life Style Change An Anthropological Perspective (1st ed.). ferozsons
Stierlin AS, De Lepeleere S, Cardon G, Dargent-Molina P, Hoffmann B, Murphy MH, Kennedy A, O'Donoghue G, Chastin SF, De Craemer M; DEDIPAC consortium
A systematic review of determinants of sedentary behaviour in youth: a DEDIPAC-study. Int J Behav Nutr Phys Act. 2015 Oct 9;12:133. doi: 10.1186/s12966-015-0291-4.

Exploring Determinants of Lifestyle Practices With Chronic Diseases Among Different Professionals in Islamabad Capital Territory: A Mixed Method Study

Details for clinical trial NCT05865717

Clinical trial NCT05865717 - References